WEST LAFAYETTE, Ind., Feb. 27, 2012 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that management will present at the upcoming Cowen and Company 32nd Annual Health Care Conference on Monday, March 5, at 2:50 p.m. EST. The conference is being held at The Boston Marriott Copley Place.
